https://www.marketscreener.com/quote/stock/OSE-IMMUNOTHERAPEUTICS-21120309/news/OSE-Immunotherapeutics-Announces-Clinical-Trial-Authorization-for-a-Phase-1-by-two-Health-Agencies--28114711/?utm_source=telegram&utm_medium=social&utm_campaign=share